Società Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board
Azioni
US21833P1030
Biotecnologia
Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
13/05 | CORBUS PHARMACEUTICALS HOLDINGS, INC. : RBC Capital Markets mantiene la raccomandazione Buy | ZM |
08/05 | CORBUS PHARMACEUTICALS HOLDINGS, INC. : giudizio positivo da Oppenheimer | ZM |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/07/13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 11/04/14 |
Chief Tech/Sci/R&D Officer | 50 | 28/02 | |
Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 01/01/14 |
Avery Catlin
BRD | Director/Board Member | 75 | 01/08/14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 01/07/13 |
John Jenkins
BRD | Director/Board Member | 66 | 05/06/18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 08/04/19 |
Yong Ben
BRD | Director/Board Member | 50 | 01/03/23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 06/03/20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 20/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 10 686 693 | 10 613 932 ( 99,32 %) | 0 | 99,32 % |
Coordinate società
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSettore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,60% | 106 Mrd | |
-4,68% | 24,28 Mrd | |
-0,82% | 21,96 Mrd | |
-10,12% | 18,16 Mrd | |
-42,12% | 16,37 Mrd | |
-17,47% | 15,56 Mrd | |
+2,77% | 13,63 Mrd | |
+34,58% | 12,27 Mrd | |
+77,64% | 8,87 Mrd |
- Borsa valori
- Azioni
- Azione CRBP
- Azione
- Società Corbus Pharmaceuticals Holdings Inc